Trial Profile
Phase Ib Study of Oncolytic Polio/Rhinovirus Recombinant Against Recurrent Malignant Glioma in Children
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Apr 2024
Price :
$35
*
At a glance
- Drugs Lerapolturev (Primary)
- Indications Astrocytoma; Ependymoma; Glioma; Medulloblastoma; Oligodendroglioma
- Focus Adverse reactions
- Sponsors Istari Oncology
- 05 Apr 2024 Status changed from active, no longer recruiting to completed.
- 12 Jul 2021 Planned primary completion date changed from 30 Jun 2021 to 30 Dec 2021.
- 30 Jun 2021 Status changed from recruiting to active, no longer recruiting.